Sibanye Stillwater drops as gold, platinum retreat from record highs

Sibanye Stillwater drops as gold, platinum retreat from record highs

NEW YORK, December 29, 2025, 14:30 ET — Regular session.

Sibanye Stillwater Limited’s U.S.-listed ADRs fell 9.4% to $14.22 in afternoon trading on Monday, as a sharp pullback in precious metals knocked mining shares lower. The stock has traded between $14.06 and $15.24 so far, with about 7.2 million shares changing hands.

The move matters because bullion — precious metals such as gold — has been the market’s momentum trade into year-end, and miners have been priced for higher realized metal prices. Monday’s reversal shows how quickly that bet can unwind when traders lock in gains.

Sibanye is highly geared to platinum-group metals (PGMs) — a family of metals including platinum and palladium — as well as gold. When those prices swing, expectations for cash flow and debt reduction can shift in a day.

Spot gold, the price for immediate delivery, fell 4.2% to $4,340.52 an ounce by midday ET after hitting a record $4,549.71 on Friday, while platinum slid nearly 13% and palladium dropped 15%, Reuters reported. “All the metals moved up to recent and all-time highs. We are seeing profit-taking pullbacks off of those spectacularly high levels,” said David Meger, director of metals trading at High Ridge Futures; TD Securities strategist Daniel Ghali also cited holiday-thinned liquidity and a looming U.S. policy deadline tied to a critical-minerals probe as factors behind the recent surge and snapback. Reuters

The South African rand weakened about 0.3% to 16.7025 per dollar in early trade as investors took profits from the metals rally, Reuters reported, a move that can filter through to dollar-priced mining ADRs. TreasuryONE’s Wichard Cilliers said the broader outlook for gold and silver remained positive in a lower-rate environment despite the short-term pullback. Reuters

The selling was not limited to Sibanye. Harmony Gold was down about 8.6%, Gold Fields fell 7.1% and AngloGold Ashanti lost 7.6% in U.S. trading.

Sibanye Stillwater is a South Africa-based mining and metals processing group with gold and PGM operations in southern Africa and the U.S. The company has flagged Feb. 20, 2026 as the date for its H2 and full-year 2025 results announcement. Sibanye-Stillwater

Investors will look for how management frames the latest metal-price volatility — and what it means for costs, capital spending and balance-sheet targets if prices stay choppy.

Near-term, traders will focus on whether gold, platinum and palladium can stabilize after Monday’s sharp drop. Markets are also watching for Fed meeting minutes and weekly jobless claims in a holiday-shortened week, with U.S. markets closed on Thursday for New Year’s Day. Reuters

For Sibanye, the metals tape may stay the main driver into year-end. A deeper retracement would pressure margin assumptions, while any rebound in platinum and palladium typically feeds quickly into the stock.

PGMs are used in catalytic converters that reduce vehicle exhaust emissions, tying demand to global auto production and emissions rules. Gold demand tends to rise when investors seek a store of value, but it can fall quickly when the market shifts back toward risk-taking.

Stock Market Today

  • Is Pediatrix Medical Group (MD) Undervalued After Nearly 58% One-Year Gain?
    January 18, 2026, 7:04 PM EST. Pediatrix Medical Group's stock surged 57.9% over the past year, trading recently near $21.86. Despite this strong run, a discounted cash flow model estimates an intrinsic value of about $37.38 per share, implying the stock could be 41.5% undervalued. The model uses projected free cash flows extending to 2035, analyzing forecasted cash flow growth. Simply Wall St's valuation framework scores Pediatrix 5 out of 6 for undervaluation potential. Investors reassessing specialized healthcare providers amid this rally may find value opportunities as the share price reflects improved sentiment but remains below longer-term intrinsic value estimates.
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears
Previous Story

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next
Next Story

JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

Go toTop